![Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin's Lymphoma: Molecular Therapy - Oncolytics Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin's Lymphoma: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/ba92b4c5-c658-4647-a746-9ee564f9095b/fx1_lrg.jpg)
Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin's Lymphoma: Molecular Therapy - Oncolytics
![Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapy - American Journal of Transplantation Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapy - American Journal of Transplantation](https://www.amjtransplant.org/cms/attachment/f6376520-4baf-4cbd-b75e-adb135006200/ga1_lrg.jpg)
Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapy - American Journal of Transplantation
![Cancers | Free Full-Text | CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells Cancers | Free Full-Text | CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells](https://www.mdpi.com/cancers/cancers-12-02612/article_deploy/html/images/cancers-12-02612-g001.png)
Cancers | Free Full-Text | CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells
![CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial | Nature Medicine CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-021-01497-1/MediaObjects/41591_2021_1497_Fig1_HTML.png)
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial | Nature Medicine
![Clinical correlation between the percentage of CD19+CD25highFoxP3high... | Download Scientific Diagram Clinical correlation between the percentage of CD19+CD25highFoxP3high... | Download Scientific Diagram](https://www.researchgate.net/publication/282584361/figure/fig5/AS:1086782993109070@1636120665939/Clinical-correlation-between-the-percentage-of-CD19-CD25highFoxP3high-cells-of-SLE.jpg)
Clinical correlation between the percentage of CD19+CD25highFoxP3high... | Download Scientific Diagram
![Cells | Free Full-Text | Maternal B Cell-Intrinsic MyD88 Signaling Mediates LPS-Driven Intrauterine Fetal Death Cells | Free Full-Text | Maternal B Cell-Intrinsic MyD88 Signaling Mediates LPS-Driven Intrauterine Fetal Death](https://pub.mdpi-res.com/cells/cells-10-02693/article_deploy/html/images/cells-10-02693-ag.png?1634115576)